Explainer: What's behind varying efficacy data for Sinovac's vaccine?

ReutersPublished: Jan 14, 2021 8:47 AM

New efficacy data from Brazil on Sinovac's Covid-19 vaccine, for which there are now four widely different success rates, raised more questions than answers, as many developing countries pin their hopes on the CoronaVac to end the pandemic.

Here are potential factors contributing to CoronaVac's varying efficacy rates and expert interpretations...

Covid-19 infection gives some immunity for at least five months but...

Deal's off if vaccine doesn’t pass muster, KJ assures amid doubts about Sinovac

New Brazil data shows only 50.4% efficacy for China's CoronaVac vaccine

Indonesia launches vaccination drive as Covid-19 deaths hit record

Sinovac vaccine cheaper as bottling to be done in M'sia - Khairy

Phamaniaga all set to manufacture Sinovac Covid-19 vaccine

Comment0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

Subscriber-only space: